Westmore · UDRP DecisionAxa-group.live
The Panel ordered transfer of <axa-group.live> to AXA SA. It found the domain confusingly similar to AXA's trademarks, found no rights or legitimate interests after the Complainant established its case and the Respondent failed to respond, and found bad-faith registration and use based on emails impersonating an AXA employee and targeting AXA customers.
The timeline behind axa-group.live
Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.
Westmore reconstructs the full history behind axa-group.live — from public RDAP and the Internet Archive — as part of UDRP Intelligence:
The decision illustrates a direct impersonation fact pattern in which an exact trademark was combined with a term closely associated with the complainant's corporate identity and then used as an email domain to contact the complainant's customers. The phishing and employee-impersonation evidence was central to the bad-faith finding, while the absence of a Response left the Complainant's prima facie showing on rights or legitimate interests unrebutted.
Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.
WIPO Arbitration and Mediation Center ADMINISTRATIVE PANEL DECISION AXA SA v. Whois Privacy, Private by Design, LLC / Stéphane Gbami Stéphane Gbami Case No. D2021-0952 1. The Parties Complainant is AXA SA, France (hereinafter “Complainant”), represented by Selarl Candé - Blanchard - Ducamp, France. Respondent is Whois Privacy, Private by Design, LLC, United States of America / Stéphane Gbami Stéphane Gbami, Ivory Coast (hereinafter, jointly and severally, “Respondent”). 2. The Domain Name and Registrar The disputed domain name <axa-group.live> is registered with Porkbun LLC (the “Registrar”). 3. Procedural History The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on March 30, 2021. On March 30, 2021, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain name. On March 30, 2021, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain name, which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to Complainant on March 31, 2021, providing the registrant and contact information disclosed by the Registrar, and inviting Complainant to submit an amendment to the Complaint. Complainant filed an amendment to the Complaint on March 31, 2021. The Center verified that the Complaint together with the amendment to the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2 and 4, the Center formally notified Respondent of the Complaint, and the proceedings commenced on April 1, 2021. In accordance with the Rules, paragraph 5, the due date for Response was April 21, 2021. Respondent did not submit any response. Accordingly, the Center notified Respondent’s default on April 22, 2021. The Center appointed M. Scott Donahey as the sole panelist in this matter on April 29, 2021. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background Complainant is a group of companies formed from a succession of mergers and acquisitions of large insurance companies from around the world. The trade name AXA was first used by Complainant in 1985. Complaint, Annex 5. The group of companies has since been referred to as the AXA Group, and Complainant is the holding company of the AXA Group. Complaint, Annex 6. AXA employs 153,000 employees worldwide, serving 105 million customers. Its three primary business involves property and casualty insurance, life insurance, and savings and asset management. Annexes 7 and 8. Complainant is present in more than 54 countries around the world. Complaint, Annex 5. Complainant is the holder of several trademarks which include the AXA name. It holds an international trademark for AXA which it filed in December 1984 (Complaint, Annex 9), an EU trademark filed in December 2009 (Complaint, Annex 11), and French trademarks for AXA and GROUP AXA, filed in January 1984 (Annexes 12 and 13). Complainant also owns domain names which incorporate AXA, including <axa.com>, registered on October 23, 1995, and <axa.net>, registered on November 1, 1997. Respondent registered the disputed domain name on January 21, 2021. Respondent has been using the disputed domain name for phishing purposes, targeting AXA’s customers by sending emails allegedly from “[name redacted]@axa-group.live” in order to collect data from them. Complaint, Annex 19. 5. Parties’ Contentions A. Complainant Complainant contends that the disputed domain name is confusingly similar to Complainant’s registered trademarks. Complainant asserts that Respondent has no rights or legitimate interests in respect of the disputed domain name, in that Complainant has never licensed or permitted Respondent to use Complainant’s registered trademarks, that Respondent has not been commonly known by the domain name and is not making a fair use of the mark without intent for commercial gain. Complainant alleges that Respondent is using the disputed domain name for phishing purposes, sending emails to Complainant’s customers. B. Respondent Respondent did not reply to Complainant’s contentions. 6. Discussion and Findings According to paragraph 15 of the Rules, “[a] Panel shall decide a complaint on the basis of the statements and documents submitted and in accordance with the Policy, these Rules and any rules and principles of law that it deems applicable”. Paragraph 4(a) of the Policy directs that the complainant must prove each of the following: (i) that the domain name registered by the respondent is identical or confusingly similar to a trademark or service mark in which the complainant has rights; and (ii) that the respondent has no rights or legitimate interests in respect of the domain name; and (iii) that the domain name has been registered and is being used in bad faith. A. Identical or Confusingly Similar The disputed domain name consists of the letters “axa”, which exactly corresponds to Complainant’s trademarks, separated by a hyphen from the word “group”. The group of companies Complainant operates is commonly known as the “AXA Group”. The term “axa-group” is appended to the generic Top-Level Domain (“gTLD”) “.live”. Accordingly, the Panel finds that the disputed domain name is confusingly similar to Complainant’s trademarks. B. Rights or Legitimate Interests While the overall burden of proof in UDRP proceedings is on the complainant, UDRP panels have recognized that proving a respondent lacks rights or legitimate interests in a domain name may result in the almost impossible task of “proving a negative”, requiring information that is often primarily within the knowledge or control of the respondent. As such, where a complainant makes out a prima facie case that the respondent lacks rights or legitimate interests, the burden of production on this element shifts to the respondent to come forward with relevant evidence demonstrating rights or legitimate interests in the domain name. If the respondent fails to come forward with such relevant evidence, the complainant is deemed to have satisfied the second element. WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition (“WIPO Overview 3.0”), section 2.1 . In the present case, Complainant alleges that Respondent has no rights or legitimate interests in respect of the disputed domain name and Respondent has failed to assert any such rights. Accordingly, the Panel finds that Respondent has no rights or legitimate interests in respect of the disputed domain name. C. Registered and Used in Bad Faith Respondent has been using the disputed domain name in contacting Complainant’s customers, using the signature of Complainant’s agent, and purporting to come from “[name redacted]@axa-group.live”. Respondent attempts to establish a relationship with Complainant’s customers by pretending to be an employee of Complainant. Accordingly, the Panel finds that Respondent has registered and is using the disputed domain name in bad faith. 7. Decision For the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the disputed domain name <axa-group.live> be transferred to Complainant. M. Scott Donahey Sole Panelist Date: May 5, 2021
Source of record: WIPO . Reproduced for research; WIPO is the authoritative source.
What Westmore sees around axa-group.live
The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.
A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.
Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.
The decision is only the beginning.
You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.
Go beyond the public record: see how this case has been cited, find comparable decisions, analyze the panelist and apply the relevant authorities to your Matter.
Westmore Professional · $395/month
Research with UDRP IntelligenceWestmore AI drafts an attorney-review-ready UDRP response from your facts, grounded in the exact panel and closest precedent.
$895 one-time per matter · no subscription required. Self-help drafting aid — not legal advice.
Build your responseWestmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.